{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:12:38Z","timestamp":1792429958804,"version":"4.5.0"},"reference-count":418,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,8,25]],"date-time":"2027-08-25T00:00:00Z","timestamp":1819152000000},"content-version":"am","delay-in-days":297,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007482","name":"Arizona State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007482","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.addr.2026.115944","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:41:22Z","timestamp":1786491682000},"page":"115944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Beyond PEG: Re-Engineering stealth-polymers to do more than just hide"],"prefix":"10.1016","volume":"238","author":[{"given":"Rachita","family":"Kiran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Kashani Asadi","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Strauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"d\u2019Arcy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2026.115944_bb0005","series-title":"Encyclop\u00e6dia Britannica","author":"Polyethylene glycol (PEG)","year":"2026"},{"key":"10.1016\/j.addr.2026.115944_bb0010","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1021\/acs.oprd.3c00428","article-title":"Striving for Uniformity: A Review on Advances and Challenges To Achieve Uniform Polyethylene Glycol","volume":"28","author":"Bento","year":"2024","journal-title":"Org. Process. Res. Dev."},{"key":"10.1016\/j.addr.2026.115944_bb0015","first-page":"460","article-title":"PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs","volume":"105","author":"Turecek","year":"2016","journal-title":"JPharmSci"},{"key":"10.1016\/j.addr.2026.115944_bb0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115944_bb0025","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.3390\/ijms23168838","article-title":"Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration","volume":"23","author":"Guerrini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41577-022-00825-x","article-title":"Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines","volume":"23","author":"Ju","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2026.115944_bb0270","first-page":"124","article-title":"Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins","volume":"70","author":"Richter","year":"1983","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.addr.2026.115944_bb0155","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s42004-022-00709-0","article-title":"Structural determination of an antibody that specifically recognizes polyethylene glycol with a terminal methoxy group","volume":"5","author":"Nguyen","year":"2022","journal-title":"Commun Chem"},{"key":"10.1016\/j.addr.2026.115944_bb0150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s42004-020-00369-y","article-title":"Structure of an anti-PEG antibody reveals an open ring that captures highly flexible PEG polymers","volume":"3","author":"Huckaby","year":"2020","journal-title":"Commun Chem"},{"key":"10.1016\/j.addr.2026.115944_bb0215","article-title":"Overcoming PEG antigenicity: statistical PEG isomers reduce antibody binding","volume":"13","author":"Deuker","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb0285","first-page":"0002","article-title":"A brush-polymer\/exendin-4 conjugate reduces blood glucose levels for up to five days and eliminates poly(ethylene glycol) antigenicity. Nat","volume":"1","author":"Qi","year":"2017","journal-title":"Biomed. Eng."},{"key":"10.1016\/j.addr.2026.115944_bb0290","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801177","article-title":"Architectural modification of conformal PEG-bottlebrush coatings minimizes anti-PEG antigenicity while preserving stealth properties","volume":"8","author":"Joh","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2026.115944_bb0305","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1021\/jacsau.5c00852","article-title":"The Role of Structural Dispersity of Polymer Brushes in Determining the Colloidal Stability of Core\u2013Shell Nanoparticles and Their Interaction with Anti-PEG Antibodies","volume":"5","author":"Pav\u00f3n","year":"2025","journal-title":"JACS Au"},{"key":"10.1016\/j.addr.2026.115944_bb0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.06.023","article-title":"The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes","volume":"213","author":"Kierstead","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0595","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jconrel.2007.02.015","article-title":"Synthesis, biodistribution and excretion of radiolabeled poly(2-alkyl-2-oxazoline)s","volume":"119","author":"Gaertner","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0600","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2016.05.048","article-title":"\u03bcPET imaging of the pharmacokinetic behavior of medium and high molar mass 89 Zr-labeled poly(2-ethyl-2-oxazoline) in comparison to poly(ethylene glycol)","volume":"235","author":"Wyffels","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0605","doi-asserted-by":"crossref","first-page":"2411354","DOI":"10.1002\/smll.202411354","article-title":"Poly(2-ethyl-2-oxazoline) (POx) as Poly(ethylene glycol) (PEG)-Lipid Substitute for Lipid Nanoparticle Formulations","volume":"21","author":"Holick","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.addr.2026.115944_bb0610","article-title":"Substituting poly(ethylene glycol) lipids with poly(2-ethyl-2-oxazoline) lipids improves lipid nanoparticle repeat dosing","volume":"13","author":"Da Silva Sanchez","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2026.115944_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120843","article-title":"Interactions of core cross-linked poly(2-oxazoline) and poly(2-oxazine) micelles with immune cells in human blood","volume":"274","author":"Leiske","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115944_bb0620","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1038\/s41467-025-57648-2","article-title":"Species differences in opsonization and phagocyte recognition of preclinical poly-2-alkyl-2-oxazoline-coated nanoparticles","volume":"16","author":"Tavano","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115944_bb0625","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/s41563-025-02408-2","volume":"24","author":"PEG alternatives for RNA therapeutics","year":"2025","journal-title":"Nat. Mater."},{"key":"10.1016\/j.addr.2026.115944_bb0630","series-title":"PVP: A Critical Review of the Kinetics and Toxicology of Polyvinylpyrrolidone (Povidone)","first-page":"0","author":"Schwarz","year":"1990"},{"key":"10.1016\/j.addr.2026.115944_bb0635","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJM195212112472403","article-title":"Polyvinyl pyrrolidone as a plasma expander; studies on its excretion, distribution and metabolism","volume":"247","author":"Ravin","year":"1952","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2026.115944_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2020.102046","article-title":"Pharmaceutical assessment of polyvinylpyrrolidone (PVP): As excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition","volume":"60","author":"Kurakula","year":"2020","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.addr.2026.115944_bb0645","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1515\/znc-2020-0077","article-title":"A tutorial translation of the description of the historically first polymer drug conjugate and its in vivo evaluation","volume":"75","author":"Luxenhofer","year":"2020","journal-title":"Z. Naturforsch. C"},{"key":"10.1016\/j.addr.2026.115944_bb0650","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0005-2736(94)90025-6","article-title":"Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo","volume":"1195","author":"Torchilin","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2026.115944_bb0655","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/pharmaceutics5040542","article-title":"Surface engineering of liposomes for stealth behavior","volume":"5","author":"Nag","year":"2013","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2026.115944_bb0660","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jconrel.2023.07.031","article-title":"Poly(vinyl pyrrolidone) derivatives as PEG alternatives for stealth, non-toxic and less immunogenic siRNA-containing lipoplex delivery","volume":"361","author":"Berger","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0665","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.humpath.2021.07.009","article-title":"Polyvinylpyrrolidone deposition disease in patients with intravenous opioid use: a case series","volume":"116","author":"Leh","year":"2021","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.addr.2026.115944_bb0670","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.addr.2009.10.004","article-title":"HPMA copolymers: Origins, early developments, present, and future\u2606","volume":"62","author":"Kope\u010dek","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115944_bb0675","first-page":"83","article-title":"Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents \u2013 drug-polymer conjugates","volume":"5","author":"Vasey","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2026.115944_bb0680","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cocis.2017.07.003","article-title":"The light at the end of the tunnel\u2014second generation HPMA conjugates for cancer treatment","volume":"31","author":"Yang","year":"2017","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.addr.2026.115944_bb0685","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3892\/ijo_00000293","article-title":"Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer","volume":"34","author":"Seymour","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.addr.2026.115944_bb0690","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2009.05.007","article-title":"Development of HPMA copolymer\u2013anticancer conjugates: Clinical experience and lessons learnt","volume":"61","author":"Duncan","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115944_bb0695","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1158\/1078-0432.CCR-03-0315","article-title":"A Phase I and Pharmacological Study of the Platinum Polymer AP5280 Given as an Intravenous Infusion Once Every 3 Weeks in Patients with Solid Tumors","volume":"10","author":"Rademaker-Lakhai","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2026.115944_bb0700","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/17425247.2016.1205585","article-title":"Clinical advances of nanocarrier-based cancer therapy and diagnostics","volume":"14","author":"Luque-Michel","year":"2017","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.addr.2026.115944_bb0705","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.addr.2009.06.004","article-title":"ProLindac\u2122 (AP5346): A review of the development of an HPMA DACH platinum Polymer Therapeutic","volume":"61","author":"Nowotnik","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115944_bb0710","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1158\/1078-0432.CCR-05-2169","article-title":"Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system","volume":"12","author":"Rice","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2026.115944_bb0715","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1021\/bc0600517","article-title":"Synthesis and characterization of AP5346, a novel polymer-linked diaminocyclohexyl platinum chemotherapeutic agent","volume":"17","author":"Sood","year":"2006","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb0720","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00280-006-0397-0","article-title":"Phase I and pharmacokinetic trial of AP5346, a DACH-platinum-polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients","volume":"60","author":"Campone","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.addr.2026.115944_bb0725","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.addr.2009.12.005","article-title":"Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities","volume":"62","author":"Duncan","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115944_bb0730","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jconrel.2014.05.001","article-title":"Polymer therapeutics: Top 10 selling pharmaceuticals \u2014 What next?","volume":"190","author":"Duncan","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0735","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/polym16040517","article-title":"Polyvinyl Alcohol, a Versatile Excipient for Pharmaceutical 3D Printing","volume":"16","author":"Cou\u021bi","year":"2024","journal-title":"Polymers"},{"key":"10.1016\/j.addr.2026.115944_bb0740","doi-asserted-by":"crossref","first-page":"2225426","DOI":"10.1155\/2021\/2225426","article-title":"Poly(vinyl alcohol) Hydrogels: The Old and New Functional Materials","volume":"2021","author":"Wang","year":"2021","journal-title":"Int. J. Polymer Sci."},{"key":"10.1016\/j.addr.2026.115944_bb0745","series-title":"510(k) summary K094018: LC bead \/ bead block","author":"U.S. Food and Drug Administration","year":"2009"},{"key":"10.1016\/j.addr.2026.115944_bb0750","series-title":"510(k) premarket notification K152157: LC bead LUMI radiopaque drug-eluting bead","author":"U.S. Food and Drug Administration","year":"2015"},{"key":"10.1016\/j.addr.2026.115944_bb0755","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.RVI.0000195323.46152.B3","article-title":"DC Bead: In Vitro Characterization of a Drug-delivery Device for Transarterial Chemoembolization","volume":"17","author":"Lewis","year":"2006","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.addr.2026.115944_bb0760","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jvir.2010.02.042","article-title":"Comparative Study of Chemoembolization Loadable Beads: In vitro Drug Release and Physical Properties of DC Bead and Hepasphere Loaded with Doxorubicin and Irinotecan","volume":"21","author":"Jordan","year":"2010","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.addr.2026.115944_bb0765","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","article-title":"Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics","volume":"46","author":"Varela","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.addr.2026.115944_bb0770","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"10.1016\/j.addr.2026.115944_bb0775","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0168-3659(01)00368-6","article-title":"Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats","volume":"75","author":"Takeuchi","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0780","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1016\/j.biomaterials.2010.05.063","article-title":"Effect of swelling of poly(vinyl alcohol) layers on complement activation","volume":"31","author":"Arima","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115944_bb0785","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1163\/156856209X426411","article-title":"Water structure and blood compatibility of poly(tetrahydrofurfuryl acrylate)","volume":"20","author":"Mochizuki","year":"2009","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.addr.2026.115944_bb0790","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0168-3659(02)00127-X","article-title":"Residual polyvinyl alcohol associated with poly (d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake","volume":"82","author":"Sahoo","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0795","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1021\/ac010368u","article-title":"Resistance to Nonspecific Protein Adsorption by Poly(vinyl alcohol) Thin Films Adsorbed to a Poly(styrene) Support Matrix Studied Using Surface Plasmon Resonance","volume":"73","author":"Barrett","year":"2001","journal-title":"Anal. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb0800","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.2042-7158.1995.tb05835.x","article-title":"Comparison of Body Distribution of Poly(vinyl alcohol) with Other Water-soluble Polymers after Intravenous Administration","volume":"47","author":"Yamaoka","year":"1995","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2026.115944_bb0805","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/374252","article-title":"Stealth Properties to Improve Therapeutic Efficacy of Drug Nanocarriers","volume":"2013","author":"Salmaso","year":"2013","journal-title":"J. Drug Delivery"},{"key":"10.1016\/j.addr.2026.115944_bb0810","doi-asserted-by":"crossref","first-page":"9264","DOI":"10.1039\/D5SC00772K","article-title":"PVAylation: precision end-functionalized poly(vinyl alcohol) for site-selective bioconjugation","volume":"16","author":"Soutar","year":"2025","journal-title":"Chem. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb1375","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/glycob\/cwx072","article-title":"Synthesis and characterization of heparosan-granulocyte-colony stimulating factor conjugates: a natural sugar-based drug delivery system to treat neutropenia","volume":"27","author":"Jing","year":"2017","journal-title":"Glycobiology"},{"key":"10.1016\/j.addr.2026.115944_bb1380","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/glycob\/cwx070","article-title":"Heparosan-coated liposomes for drug delivery","volume":"27","author":"Lane","year":"2017","journal-title":"Glycobiology"},{"key":"10.1016\/j.addr.2026.115944_bb1385","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1074\/jbc.M112130200","article-title":"Identification and Molecular Cloning of a Heparosan Synthase fromPasteurella multocida Type D","volume":"277","author":"DeAngelis","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb1390","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1021\/acs.nanolett.2c00349","article-title":"Nanoparticle surface engineering with heparosan polysaccharide reduces serum protein adsorption and enhances cellular uptake","volume":"22","author":"Yang","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2026.115944_bb1395","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1007\/PL00000676","article-title":"Polysialic acids: potential in improving the stability and pharmacokinetics of proteins and other therapeutics","volume":"57","author":"Gregoriadis","year":"2000","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.addr.2026.115944_bb1400","doi-asserted-by":"crossref","first-page":"7397","DOI":"10.1073\/pnas.1019266108","article-title":"Site-specific enzymatic polysialylation of therapeutic proteins using bacterial enzymes","volume":"108","author":"Lindhout","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb1405","series-title":"Half-Life Extension through HESylation\u00ae. in Therapeutic Proteins 117\u2013140","author":"Hey","year":"2012"},{"key":"10.1016\/j.addr.2026.115944_bb1410","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejpb.2014.03.010","article-title":"Protein HESylation for half-life extension: Synthesis, characterization and pharmacokinetics of HESylated anakinra","volume":"87","author":"Liebner","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2026.115944_bb1415","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/jps.24253","article-title":"Head to head comparison of the formulation and stability of concentrated solutions of HESylated versus PEGylated anakinra","volume":"104","author":"Liebner","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb1420","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cej.2018.05.082","article-title":"Hydroxyethyl starch stabilized polydopamine nanoparticles for cancer chemotherapy","volume":"349","author":"Wu","year":"2018","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.addr.2026.115944_bb1425","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2020.110079","article-title":"Main-chain water-soluble polyphosphoesters: multi-functional polymers as degradable PEG-alternatives for biomedical applications","volume":"141","author":"Pelosi","year":"2020","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.addr.2026.115944_bb1430","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1021\/acs.biomac.6b01107","article-title":"Degradable polyphosphoester-protein conjugates: \u2018PPEylation\u2019 of proteins","volume":"17","author":"Steinbach","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115944_bb1435","doi-asserted-by":"crossref","first-page":"1600377","DOI":"10.1002\/mabi.201600377","article-title":"Reversible bioconjugation: biodegradable poly(phosphate)-protein conjugates","volume":"17","author":"Steinbach","year":"2017","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.addr.2026.115944_bb1440","doi-asserted-by":"crossref","first-page":"23814","DOI":"10.1021\/acsnano.3c07932","article-title":"Poly(ethyl ethylene phosphate): overcoming the \u2018polyethylene glycol dilemma\u2019 for cancer immunotherapy and mRNA vaccination","volume":"17","author":"Yu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115944_bb1445","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1021\/acs.biomac.1c00058","article-title":"Effect of Polymer Hydrophilicity and Molar Mass on the Properties of the Protein in Protein\u2013Polymer Conjugates: The Case of PPEylated Myoglobin","volume":"22","author":"Pelosi","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115944_bb1450","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.actbio.2020.09.016","article-title":"Polyphosphoester surfactants as general stealth coatings for polymeric nanocarriers","volume":"116","author":"Bauer","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2026.115944_bb1455","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1002\/anie.201800272","article-title":"Hydrophilicity Regulates the Stealth Properties of Polyphosphoester-Coated Nanocarriers","volume":"57","author":"Simon","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115944_bb1460","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1021\/acsabm.1c01210","article-title":"Blood compatibility of hydrophilic polyphosphoesters","volume":"5","author":"Pelosi","year":"2022","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.addr.2026.115944_bb1465","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/protein\/gzt023","article-title":"PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins","volume":"26","author":"Schlapschy","year":"2013","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.addr.2026.115944_bb1470","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1021\/mp5007147","article-title":"PASylation of Murine Leptin Leads to Extended Plasma Half-Life and Enhanced in Vivo Efficacy","volume":"12","author":"Morath","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115944_bb1475","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nbt.1588","article-title":"A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner","volume":"27","author":"Schellenberger","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2026.115944_bb1480","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/protein\/gzt048","article-title":"Extension of in vivo half-life of biologically active peptides via chemical conjugation to XTEN protein polymer","volume":"26","author":"Podust","year":"2013","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.addr.2026.115944_bb1485","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1021\/bc500215m","article-title":"Multivalent antiviral XTEN-peptide conjugates with long in vivo half-life and enhanced solubility","volume":"25","author":"Ding","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb1490","article-title":"Genetically encoded XTEN-based hydrogels with tunable viscoelasticity and biodegradability for injectable cell therapies","volume":"11","author":"Bennett","year":"2024","journal-title":"Advanced Science"},{"key":"10.1016\/j.addr.2026.115944_bb1495","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s40265-023-01866-9","article-title":"Efanesoctocog Alfa: First Approval","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.addr.2026.115944_bb1955","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.eurpolymj.2016.09.052","article-title":"Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson\u2019s disease \u2013 Proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications","volume":"88","author":"Moreadith","year":"2017","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.addr.2026.115944_bb1500","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1021\/acs.biomac.5b01031","article-title":"EKylation: addition of an alternating-charge peptide stabilizes proteins","volume":"16","author":"Liu","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115944_bb1505","doi-asserted-by":"crossref","first-page":"22378","DOI":"10.1002\/anie.202004995","article-title":"Zwitterionic peptide cloak mimics protein surfaces for protein protection","volume":"59","author":"Yuan","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115944_bb1510","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1039\/C7BM00747G","article-title":"Zwitterionic stealth peptide-protected gold nanoparticles enable long circulation without the accelerated blood clearance phenomenon","volume":"6","author":"Zhao","year":"2018","journal-title":"Biomaterials Science"},{"key":"10.1016\/j.addr.2026.115944_bb1515","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.biomaterials.2018.11.012","article-title":"Long circulating genetically encoded intrinsically disordered zwitterionic polypeptides for drug delivery","volume":"192","author":"Banskota","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115944_bb1520","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1002\/anie.201802452","article-title":"Polypeptides with high zwitterion density for safe and effective therapeutics","volume":"57","author":"Zhang","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115944_bb1525","first-page":"113","article-title":"Zwitterionic peptides: tunable next-generation stealth nanoparticle modifications","volume":"27","author":"Overby","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.addr.2026.115944_bb1530","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13036-026-00636-x","article-title":"Biosynthesized uricase with dual-terminus zwitterionic EKylation for prolonged elimination half-life and reduced immunogenicity","volume":"20","author":"Xu","year":"2026","journal-title":"J. Biol. Eng."},{"key":"10.1016\/j.addr.2026.115944_bb1535","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jcis.2023.07.149","article-title":"Polysarcosine-Coated liposomes attenuating immune response induction and prolonging blood circulation","volume":"651","author":"Hu","year":"2023","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.addr.2026.115944_bb1540","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1021\/acs.bioconjchem.8b00237","article-title":"Polysarcosine as an Alternative to PEG for Therapeutic Protein Conjugation","volume":"29","author":"Hu","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb1545","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1021\/ml500112u","article-title":"Factors Influencing in Vivo Disposition of Polymeric Micelles on Multiple Administrations","volume":"5","author":"Hara","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.addr.2026.115944_bb1550","article-title":"Nanourchin-like Uricase-Poly(L-proline) Conjugate with Retained Enzymatic Activity, Mitigated Immunogenicity, and Sustained Efficacy Upon Repeated Administrations","volume":"64","author":"Zhao","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115944_bb1620","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1021\/mp2000428","article-title":"Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes","volume":"8","author":"Qhattal","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115944_bb1635","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1016\/j.biomaterials.2012.02.016","article-title":"Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy","volume":"33","author":"Yoon","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115944_bb1640","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biomaterials.2009.09.030","article-title":"Self-assembled hyaluronic acid nanoparticles for active tumor targeting","volume":"31","author":"Choi","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115944_bb1645","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1038\/srep08509","article-title":"MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer","volume":"5","author":"Yang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2026.115944_bb1650","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1593\/neo.03460","article-title":"Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal doxorubicin in syngeneic and human xenograft mouse tumor models","volume":"6","author":"Peer","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.addr.2026.115944_bb1655","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1021\/nn405839n","article-title":"Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes","volume":"8","author":"Qhattal","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115944_bb1660","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.3390\/ijms21103504","article-title":"Role of the hyaluronan receptor, stabilin-2\/HARE, in health and disease","volume":"21","author":"Baker","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb1665","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/biom9090454","article-title":"Discovery of the Liver Hyaluronan Receptor for Endocytosis (HARE) and Its Progressive Emergence as the Multi-Ligand Scavenger Receptor Stabilin-2","volume":"9","author":"Weigel","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.addr.2026.115944_bb1670","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.molimm.2009.08.026","article-title":"Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS","volume":"47","author":"Muto","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.addr.2026.115944_bb1675","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40824-021-00228-4","article-title":"The effects of the molecular weights of hyaluronic acid on the immune responses","volume":"25","author":"Lee","year":"2021","journal-title":"Biomater Res"},{"key":"10.1016\/j.addr.2026.115944_bb1680","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.2147\/IJN.S257164","article-title":"Mechanism investigation of hyaluronidase-combined multistage nanoparticles for solid tumor penetration and antitumor effect","volume":"15","author":"Chen","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2026.115944_bb1685","doi-asserted-by":"crossref","first-page":"7208","DOI":"10.1158\/0008-5472.CAN-16-1681","article-title":"A hyaluronidase-responsive nanoparticle-based drug delivery system for targeting colon cancer cells","volume":"76","author":"Zhang","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2026.115944_bb1695","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13046-024-03028-5","article-title":"A paclitaxel-hyaluronan conjugate (ONCOFID-P-B\u2122) in patients with BCG-unresponsive carcinoma in situ of the bladder: a dynamic assessment of the tumor microenvironment","volume":"43","author":"Tosi","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.addr.2026.115944_bb1700","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112475","article-title":"Double-responsive hyaluronic acid-based prodrugs for efficient tumour targeting","volume":"131","author":"Quagliariello","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.addr.2026.115944_bb1705","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1021\/bc9900338","article-title":"Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate","volume":"10","author":"Luo","year":"1999","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb1950","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1520274","article-title":"Hyaluronic acid\u2013targeted topotecan liposomes improve therapeutic efficacy against lung cancer in animals","volume":"14","author":"Xue","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.addr.2026.115944_bb0975","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.colsurfb.2017.05.053","article-title":"In vitro and in vivo anti-tumor efficiency comparison of phosphorylcholine micelles with PEG micelles","volume":"157","author":"Cai","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.addr.2026.115944_bb0980","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114306","article-title":"Polyphosphocholination of liposomic vehicles extends blood circulation, enhances cellular uptake, and lowers immunogenicity relative to PEGylation","volume":"388","author":"Kluzek","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb1710","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1021\/acscentsci.2c00146","article-title":"A Multiscale Study of Phosphorylcholine Driven Cellular Phenotypic Targeting","volume":"8","author":"Acosta-Guti\u00e9rrez","year":"2022","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb1715","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1021\/acsnano.7b01110","article-title":"Zwitterionic nanocarrier surface chemistry improves siRNA tumor delivery and silencing activity relative to polyethylene glycol","volume":"11","author":"Jackson","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115944_bb1720","doi-asserted-by":"crossref","first-page":"8287","DOI":"10.1021\/acsnano.0c01870","article-title":"Polymersomes eradicating intracellular bacteria","volume":"14","author":"Fenaroli","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115944_bb1725","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120528","article-title":"Kupffer Cell Release of Platelet Activating Factor Drives Dose Limiting Toxicities of Nucleic Acid Nanocarriers","volume":"268","author":"Jackson","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115944_bb1730","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1021\/bc800242t","article-title":"Poly(2-methacryloyloxyethyl phosphorylcholine) for Protein Conjugation","volume":"19","author":"Lewis","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb1735","unstructured":"Summary of Safety and Effectiveness Data (SSED): Endeavor Zotarolimus-Eluting Coronary Stent System. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf6\/P060033B.pdf (2008)."},{"key":"10.1016\/j.addr.2026.115944_bb1945","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1007\/s12274-016-0991-3","article-title":"Phosphorylcholine polymer nanocapsules prolong the circulation time and reduce the immunogenicity of therapeutic proteins","volume":"9","author":"Liang","year":"2016","journal-title":"Nano Res."},{"key":"10.1016\/j.addr.2026.115944_bb1740","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/cdd.2016.11","article-title":"Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer","volume":"23","author":"Birge","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.addr.2026.115944_bb1745","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tcb.2015.08.003","article-title":"An Apoptotic \u2018Eat Me\u2019 Signal: Phosphatidylserine Exposure","volume":"25","author":"Segawa","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.addr.2026.115944_bb1750","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41428-025-01140-7","article-title":"Molecular design of phosphatidylserine-inspired polymers for efficient anti-inflammatory therapy via enhanced interaction with Tim-4","volume":"58","author":"Sato","year":"2026","journal-title":"Polym. J."},{"key":"10.1016\/j.addr.2026.115944_bb1755","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1073\/pnas.1015623108","article-title":"Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair","volume":"108","author":"Harel-Adar","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb1760","doi-asserted-by":"crossref","first-page":"eaba0754","DOI":"10.1126\/sciadv.aba0754","article-title":"De novo design of functional zwitterionic biomimetic material for immunomodulation.","volume":"6","author":"Li","year":"2020","journal-title":"Science Advances"},{"key":"10.1016\/j.addr.2026.115944_bb1765","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103196","article-title":"Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes","volume":"145","author":"Garcia-Loza","year":"2024","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.addr.2026.115944_bb1770","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1556-276X-9-176","article-title":"In vitro uptake of apoptotic body mimicking phosphatidylserine-quantum dot micelles by monocytic cell line","volume":"9","author":"Maiseyeu","year":"2014","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.addr.2026.115944_bb1775","doi-asserted-by":"crossref","first-page":"20507","DOI":"10.1021\/jacs.2c09484","article-title":"Mitigating the Immunogenicity of AAV-Mediated Gene Therapy with an Immunosuppressive Phosphoserine-Containing Zwitterionic Peptide","volume":"144","author":"Yuan","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115944_bb1780","doi-asserted-by":"crossref","first-page":"8304","DOI":"10.1021\/acs.nanolett.2c03234","article-title":"Phosphatidylserine Lipid Nanoparticles Promote Systemic RNA Delivery to Secondary Lymphoid Organs","volume":"22","author":"Luozhong","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2026.115944_bb1785","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jconrel.2015.09.027","article-title":"Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals","volume":"217","author":"Bagalkot","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb1790","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf7374","article-title":"P-selectin is a nanotherapeutic delivery target in the tumor microenvironment","volume":"8","author":"Shamay","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2026.115944_bb1795","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.canlet.2020.11.021","article-title":"Fucoidan-coated nanoparticles target radiation-induced P-selectin to enhance chemoradiotherapy in murine colorectal cancer","volume":"500","author":"DuRoss","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.addr.2026.115944_bb1800","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41563-023-01481-9","article-title":"P-selectin-targeted nanocarriers induce active crossing of the blood\u2013brain barrier via caveolin-1-dependent transcytosis","volume":"22","author":"Tylawsky","year":"2023","journal-title":"Nat. Mater."},{"key":"10.1016\/j.addr.2026.115944_bb1805","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aab3459","article-title":"Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation","volume":"7","author":"Spence","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2026.115944_bb1810","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/glycob\/cwr087","article-title":"Letter to the Glyco-Forum: Since there are PAMPs and DAMPs, there must be SAMPs? Glycan \u201cself-associated molecular patterns\u201d dampen innate immunity, but pathogens can mimic them","volume":"21","author":"Varki","year":"2011","journal-title":"Glycobiology"},{"key":"10.1016\/j.addr.2026.115944_bb1815","doi-asserted-by":"crossref","first-page":"962","DOI":"10.7150\/thno.19061","article-title":"Development of sialic acid-coated nanoparticles for targeting cancer and efficient evasion of the immune system","volume":"7","author":"Kim","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2026.115944_bb1820","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1021\/bc200405d","article-title":"89Zr-labeled dextran nanoparticles enable in vivo macrophage imaging","volume":"22","author":"Keliher","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb1825","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1021\/acs.molpharmaceut.7b00507","article-title":"Surface modification of polysaccharide-based nanoparticles with PEG and dextran and the effects on immune cell binding and stimulatory characteristics","volume":"14","author":"Bamberger","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115944_bb1835","doi-asserted-by":"crossref","first-page":"30540","DOI":"10.1021\/acsnano.4c08922","article-title":"Glycopolymeric Nanoparticles Enrich Less Immunogenic Protein Coronas, Reduce Mononuclear Phagocyte Clearance, and Improve Tumor Delivery Compared to PEGylated Nanoparticles","volume":"18","author":"Hulugalla","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115944_bb1840","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0168-3659(00)00368-0","article-title":"Evidence for receptor-mediated hepatic uptake of pullulan in rats","volume":"70","author":"Kaneo","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb1845","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1074\/jbc.271.12.6686","article-title":"Selective Sugar Binding to the Carbohydrate Recognition Domains of the Rat Hepatic and Macrophage Asialoglycoprotein Receptors","volume":"271","author":"Iobst","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb1850","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.2147\/IJN.S377354","article-title":"Sorafenib-entrapped, self-assembled pullulan\u2013stearic acid biopolymer-derived drug delivery system to PLC\/PRF\/5 hepatocellular carcinoma model","volume":"17","author":"Chirayil","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2026.115944_bb1855","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejps.2017.02.016","article-title":"Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells","volume":"103","author":"Balasso","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb1860","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1039\/C4NR03962A","article-title":"Biocompatible mannosylated endosomal-escape nanoparticles enhance selective delivery of short nucleotide sequences to tumor associated macrophages","volume":"7","author":"Ortega","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.addr.2026.115944_bb1865","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100368","article-title":"Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206","volume":"296","author":"Feinberg","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb1870","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1186\/s12885-022-09612-2","article-title":"Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer","volume":"22","author":"Glass","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.addr.2026.115944_bb1880","doi-asserted-by":"crossref","first-page":"2101651","DOI":"10.1002\/adhm.202101651","article-title":"Well-Defined Mannosylated Polymer for Peptide Vaccine Delivery with Enhanced Antitumor Immunity","volume":"11","author":"Lv","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2026.115944_bb1885","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/acscentsci.3c01310","article-title":"Mannosylated STING Agonist Drugamers for Dendritic Cell-Mediated Cancer Immunotherapy","volume":"10","author":"Nguyen","year":"2024","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb1890","doi-asserted-by":"crossref","first-page":"23134","DOI":"10.1021\/jacs.2c10757","article-title":"Sulfation at Glycopolymer Side Chains Switches Activity at the Macrophage Mannose Receptor (CD206) In Vitro and In Vivo","volume":"144","author":"Mastrotto","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115944_bb0035","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1529\/biophysj.105.059428","article-title":"Strong repulsive forces between protein and oligo (ethylene glycol) self-assembled monolayers: a molecular simulation study","volume":"89","author":"Zheng","year":"2005","journal-title":"Biophys. J."},{"key":"10.1016\/j.addr.2026.115944_bb0040","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2026.115944_bb0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","volume":"307","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2026.115944_bb0050","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0169-409X(02)00022-4","article-title":"Chemistry for peptide and protein PEGylation","volume":"54","author":"Roberts","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115944_bb0055","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115944_bb0060","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41467-017-00622-4","article-title":"A genome-wide association study identifies a novel susceptibility locus for the immunogenicity of polyethylene glycol","volume":"8","author":"Chang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115944_bb0065","doi-asserted-by":"crossref","first-page":"11804","DOI":"10.1021\/acs.analchem.6b03437","article-title":"Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population","volume":"88","author":"Yang","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb0070","first-page":"36","article-title":"Polyethylene Glycol Reactive Antibodies in Man: Titer Distribution in Allergic Patients Treated with Monomethoxy Polyethylene Glycol Modified Allergens or Placebo, and in Healthy Blood Donors","volume":"74","author":"Richter","year":"1984","journal-title":"International Archives of Allergy and Applied Immunology"},{"key":"10.1016\/j.addr.2026.115944_bb0075","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jconrel.2016.06.040","article-title":"Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation","volume":"244","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154\u2013155","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115944_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics3010001","article-title":"Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats","volume":"3","author":"Ichihara","year":"2011","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2026.115944_bb0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2007.11.005","article-title":"Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes","volume":"354","author":"Ishida","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2026.115944_bb0095","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2013.07.026","article-title":"The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage","volume":"172","author":"Abu Lila","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0100","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-3565(24)35391-1","article-title":"Accelerated Blood Clearance and Altered Biodistribution of Repeated Injections of Sterically Stabilized Liposomes","volume":"292","author":"Dams","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2026.115944_bb0105","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.actbio.2023.08.052","article-title":"Pegloticase co-administered with high MW polyethylene glycol effectively reduces PEG-immunogenicity and restores prolonged circulation in mouse","volume":"170","author":"Li","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2026.115944_bb0110","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/jama.2011.1169","article-title":"Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials","volume":"306","author":"Sundy","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2026.115944_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103672","article-title":"Polyethylene glycol-like brush polymer conjugate of a protein drug does not induce an antipolymer immune response and has enhanced pharmacokinetics than its polyethylene glycol counterpart","volume":"9","author":"Ozer","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3324\/haematol.2020.258525","article-title":"Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia","volume":"107","author":"Khalil","year":"2022","journal-title":"haematol"},{"key":"10.1016\/j.addr.2026.115944_bb0125","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/annonc\/mdg374","article-title":"Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil\u00ae): possible role in hypersensitivity reactions","volume":"14","author":"Chanan-Khan","year":"2003","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.addr.2026.115944_bb0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.molimm.2014.06.038","article-title":"Complement activation-related pseudoallergy: A stress reaction in blood triggered by nanomedicines and biologicals","volume":"61","author":"Szebeni","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.addr.2026.115944_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1208\/s12248-020-0420-0","article-title":"Immunogenicity Risk Assessment for PEGylated Therapeutics","volume":"22","author":"Mora","year":"2020","journal-title":"AAPS J."},{"key":"10.1016\/j.addr.2026.115944_bb0140","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.jaci.2016.04.058","article-title":"Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer","volume":"138","author":"Povsic","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.addr.2026.115944_bb0145","doi-asserted-by":"crossref","first-page":"1800699","DOI":"10.1002\/marc.201800699","article-title":"Oxidation-responsive materials: biological rationale, state of the art, multiple responsiveness, and open issues","volume":"40","author":"El-Mohtadi","year":"2019","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.addr.2026.115944_bb1130","doi-asserted-by":"crossref","first-page":"21304","DOI":"10.1021\/jacs.2c09232","article-title":"A Reactive Oxygen Species-Scavenging \u2018Stealth\u2019 Polymer, Poly(thioglycidyl glycerol), Outperforms Poly(ethylene glycol) in Protein Conjugates and Nanocarriers and Enhances Protein Stability to Environmental and Biological Stressors","volume":"144","author":"d\u2019Arcy","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115944_bb0160","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2020.04.011","article-title":"Hepatosplenic phagocytic cells indirectly contribute to anti-PEG IgM production in the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes: Appearance of an unexplained mechanism in the ABC phenomenon","volume":"323","author":"El Sayed","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0165","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12951-025-03209-0","article-title":"Emerging strategies against accelerated blood clearance phenomenon of nanocarrier drug delivery systems","volume":"23","author":"Pan","year":"2025","journal-title":"Journal of Nanobiotechnology"},{"key":"10.1016\/j.addr.2026.115944_bb0170","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijpharm.2010.03.022","article-title":"T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes","volume":"392","author":"Koide","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2026.115944_bb0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2006.01.005","article-title":"Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes","volume":"112","author":"Ishida","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0180","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jconrel.2006.08.001","article-title":"Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes","volume":"115","author":"Ishida","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0185","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4049\/immunohorizons.1900029","article-title":"Accelerated Blood Clearance of Lipid Nanoparticles Entails a Biphasic Humoral Response of B-1 Followed by B-2 Lymphocytes to Distinct Antigenic Moieties","volume":"3","author":"Besin","year":"2019","journal-title":"ImmunoHorizons"},{"key":"10.1016\/j.addr.2026.115944_bb0190","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11095-018-2505-3","article-title":"A Cell Assay for Detecting Anti-PEG Immune Response against PEG-Modified Therapeutics","volume":"35","author":"Shimizu","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2026.115944_bb0195","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1021\/acsnano.2c12193","article-title":"Antibodies against poly(ethylene glycol) activate innate immune cells and induce hypersensitivity reactions to PEGylated nanomedicines","volume":"17","author":"Chen","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115944_bb0200","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0022-3565(24)29419-2","article-title":"Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection","volume":"298","author":"Laverman","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2026.115944_bb0205","doi-asserted-by":"crossref","first-page":"9315","DOI":"10.1021\/acsnano.9b03942","article-title":"Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions","volume":"13","author":"Kozma","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115944_bb0210","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12929-019-0589-7","article-title":"Structural basis of polyethylene glycol recognition by antibody","volume":"27","author":"Lee","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb0220","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1021\/am9005463","article-title":"Complement Activation by Polymers Carrying Hydroxyl Groups","volume":"1","author":"Arima","year":"2009","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2026.115944_bb0225","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.molimm.2008.08.276","article-title":"Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process","volume":"46","author":"Hamad","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.addr.2026.115944_bb0230","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/pro.5560060201","article-title":"The internal thioester and the covalent binding properties of the complement proteins C3 and C4","volume":"6","author":"Law","year":"1997","journal-title":"Protein Sci."},{"key":"10.1016\/j.addr.2026.115944_bb0235","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.biomaterials.2010.11.037","article-title":"Engineering complement activation on polypropylene sulfide vaccine nanoparticles","volume":"32","author":"Thomas","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115944_bb0240","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejpb.2018.02.019","article-title":"A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes","volume":"127","author":"Shimizu","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2026.115944_bb0245","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1021\/acsnano.8b01806","article-title":"C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes","volume":"12","author":"Tavano","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115944_bb0250","doi-asserted-by":"crossref","first-page":"10758","DOI":"10.1021\/acsnano.5b05061","article-title":"Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake","volume":"9","author":"Inturi","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115944_bb0255","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/nbt1332","article-title":"Exploiting lymphatic transport and complement activation in nanoparticle vaccines","volume":"25","author":"Reddy","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2026.115944_bb0260","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2006.01.006","article-title":"In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles","volume":"112","author":"Reddy","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0265","author":"Ding"},{"key":"10.1016\/j.addr.2026.115944_bb0275","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.1021\/acs.molpharmaceut.4c00628","article-title":"Effect of Anti-PEG Antibody on Immune Response of mRNA-Loaded Lipid Nanoparticles","volume":"21","author":"Omata","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115944_bb0280","doi-asserted-by":"crossref","first-page":"1266082","DOI":"10.3389\/fimmu.2023.1266082","article-title":"Characterization of pre-existing anti-PEG and anti-AGAL antibodies towards PRX-102 in patients with fabry disease","volume":"14","author":"Lenders","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2026.115944_bb0295","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1021\/ma0347971","article-title":"Synthesis of Thermally Sensitive Water-Soluble Polymethacrylates by Living Anionic Polymerizations of Oligo(ethylene glycol) Methyl Ether Methacrylates","volume":"36","author":"Han","year":"2003","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2026.115944_bb0300","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202107852","article-title":"PEG-like brush polymer conjugate of RNA aptamer that shows reversible anticoagulant activity and minimal immune response","volume":"34","author":"Ozer","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2026.115944_bb0310","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1021\/bc000082g","article-title":"Rational Design of a Potent, Long-Lasting Form of Interferon: A 40 kDa Branched Polyethylene Glycol-Conjugated Interferon \u03b1-2a for the Treatment of Hepatitis C","volume":"12","author":"Bailon","year":"2001","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb0315","doi-asserted-by":"crossref","first-page":"e2605","DOI":"10.1210\/clinem\/dgae816","article-title":"A Novel Y-Shaped Pegylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency","volume":"110","author":"Liang","year":"2025","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.addr.2026.115944_bb0320","article-title":"\u201cY-type\u201d PEG modified liposomes could eliminate the accelerated blood clearance (ABC) phenomenon and improved tumor therapy","volume":"32","author":"Liu","year":"2023","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.addr.2026.115944_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121415","article-title":"Branched PEG-modification: A new strategy for nanocarriers to evade of the accelerated blood clearance phenomenon and enhance anti-tumor efficacy","volume":"283","author":"Liu","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115944_bb0330","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jconrel.2025.02.001","article-title":"The strategy used by na\u00efve anti-PEG antibodies to capture flexible and featureless PEG chains","volume":"380","author":"Liu","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0335","article-title":"In Vitro and in Vivo Behavior of Liposomes Decorated with PEGs with Different Chemical Features","volume":"acs.molpharmaceut.9b00887","author":"Mastrotto","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115944_bb0340","article-title":"Isomerization of Poly(ethylene glycol): A Strategy for the Evasion of Anti-PEG Antibody Recognition","volume":"10","author":"Dreier","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115944_bb0345","article-title":"A non-antigenic randomized polyethylene glycol\/poly(2-phenyl-2-oxazine)-based drug delivery platform","volume":"10","author":"Schmidt","year":"2025","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.addr.2026.115944_bb0350","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2019.08.017","article-title":"Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEG","volume":"311\u2013312","author":"McSweeney","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0355","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jconrel.2020.10.011","article-title":"Pre-treatment with high molecular weight free PEG effectively suppresses anti-PEG antibody induction by PEG-liposomes in mice","volume":"329","author":"McSweeney","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0360","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jconrel.2012.02.029","article-title":"Prevention of infusion reactions to PEGylated liposomal doxorubicin via tachyphylaxis induction by placebo vesicles: a porcine model","volume":"160","author":"Szebeni","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0365","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2019.06.007","article-title":"Doxebo (doxorubicin-free Doxil-like liposomes) is safe to use as a pre-treatment to prevent infusion reactions to PEGylated nanodrugs","volume":"306","author":"Bavli","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0370","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/s41563-020-0755-z","article-title":"The dose threshold for nanoparticle tumour delivery","volume":"19","author":"Ouyang","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.addr.2026.115944_bb0375","first-page":"318","article-title":"Accelerated clearance by antibodies against methoxy PEG depends on pegylation architecture","volume":"353","author":"Lin","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0380","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jconrel.2006.08.017","article-title":"Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection","volume":"115","author":"Ishida","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0385","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ijpharm.2012.07.049","article-title":"Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs","volume":"436","author":"Suzuki","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2026.115944_bb0390","article-title":"Folic acid ameliorates the immunogenicity of PEGylated liposomes","volume":"36","author":"Wu","year":"2025","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.addr.2026.115944_bb0395","first-page":"479","article-title":"Slow intravenous infusion reduces the accelerated blood clearance of PEGylated liposomes by removing anti-PEG antibodies","volume":"379","author":"Zheng","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0400","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10717544.2017.1388451","article-title":"Cleavable PEGylation: a strategy for overcoming the \u201cPEG dilemma\u201d in efficient drug delivery","volume":"24","author":"Fang","year":"2017","journal-title":"Drug Delivery"},{"key":"10.1016\/j.addr.2026.115944_bb0405","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1039\/C8NH00417J","article-title":"DePEGylation strategies to increase cancer nanomedicine efficacy","volume":"4","author":"Kong","year":"2019","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.addr.2026.115944_bb0410","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jconrel.2010.03.016","article-title":"Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting","volume":"145","author":"Li","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0415","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11095-007-9348-7","article-title":"Sheddable coatings for long-circulating nanoparticles","volume":"25","author":"Romberg","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2026.115944_bb0420","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10555-019-09792-7","article-title":"Causes, consequences, and therapy of tumor acidosis","volume":"38","author":"Pillai","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.addr.2026.115944_bb0425","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(03)00232-3","article-title":"Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG\u2013lipids","volume":"91","author":"Shin","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0430","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1021\/bc300266y","article-title":"Acid-Triggered Release via dePEGylation of Fusogenic Liposomes Mediated by Heterobifunctional Phenyl-Substituted Vinyl Ethers with Tunable pH-Sensitivity","volume":"23","author":"Kim","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb0435","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1021\/bc000110v","article-title":"Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG-diortho ester-lipid conjugate","volume":"12","author":"Guo","year":"2001","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb0445","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/08982100701525035","article-title":"\u201cSmart\u201d Drug Carriers: PEGylated TATp-Modified pH-Sensitive Liposomes","volume":"17","author":"Kale","year":"2007","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.addr.2026.115944_bb0440","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jconrel.2011.12.002","article-title":"Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity","volume":"160","author":"Koren","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0450","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/anie.201509507","article-title":"Facile Generation of Tumor-pH-Labile Linkage-Bridged Block Copolymers for Chemotherapeutic Delivery","volume":"55","author":"Sun","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115944_bb0455","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1039\/D2TB00695B","article-title":"Tumor acidity-responsive polymeric nanoparticles to promote intracellular delivery of zoledronic acid by PEG detachment and positive charge exposure for enhanced antitumor potency","volume":"10","author":"Chou","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.addr.2026.115944_bb0460","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1021\/ja044941d","article-title":"Lactosylated Poly(ethylene glycol)-siRNA Conjugate through Acid-Labile \u03b2-Thiopropionate Linkage to Construct pH-Sensitive Polyion Complex Micelles Achieving Enhanced Gene Silencing in Hepatoma Cells","volume":"127","author":"Oishi","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115944_bb0465","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1021\/ja800336v","article-title":"PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors","volume":"130","author":"Takae","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115944_bb0470","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.7150\/thno.37128","article-title":"On-demand PEGylation and dePEGylation of PLA-based nanocarriers via amphiphilic mPEG-TK-Ce6 for nanoenabled cancer chemotherapy","volume":"9","author":"Zhu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2026.115944_bb0475","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.biomaterials.2018.04.015","article-title":"Photoinduced PEG deshielding from ROS-sensitive linkage-bridged block copolymer-based nanocarriers for on-demand drug delivery","volume":"170","author":"Li","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115944_bb0480","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/polym14040687","article-title":"Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines","volume":"14","author":"Rinaldi","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.addr.2026.115944_bb0485","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nmat2859","article-title":"Orally delivered thioketal nanoparticles loaded with TNF-alpha-siRNA target inflammation and inhibit gene expression in the intestines","volume":"9","author":"Wilson","year":"2010","journal-title":"Nat. Mater."},{"key":"10.1016\/j.addr.2026.115944_bb0490","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1021\/acsmacrolett.3c00323","article-title":"Hydrogen peroxide-triggered disassembly of boronic ester-cross-linked brush-arm star polymers","volume":"12","author":"Costa","year":"2023","journal-title":"ACS Macro Lett."},{"key":"10.1016\/j.addr.2026.115944_bb0495","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1039\/C9PY00171A","article-title":"ROS-triggered degradation of selenide-containing polymers based on selenoxide elimination","volume":"10","author":"Wang","year":"2019","journal-title":"Polym. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb0500","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/srep02233","article-title":"H2O2-responsive molecularly engineered polymer nanoparticles as ischemia\/reperfusion-targeted nanotherapeutic agents","volume":"3","author":"Lee","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2026.115944_bb0505","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jconrel.2013.09.020","article-title":"Hydrogen peroxide-responsive copolyoxalate nanoparticles for detection and therapy of ischemia-reperfusion injury","volume":"172","author":"Lee","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0510","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1016\/j.biomaterials.2011.02.045","article-title":"Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid","volume":"32","author":"Hatakeyama","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115944_bb0515","doi-asserted-by":"crossref","first-page":"17047","DOI":"10.1073\/pnas.1304987110","article-title":"Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety","volume":"110","author":"Zhu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.addr.2026.115944_bb0520","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1039\/C5CC09164K","article-title":"Dual-responsive nanoparticles release cargo upon exposure to matrix metalloproteinase and reactive oxygen species","volume":"52","author":"Daniel","year":"2016","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2026.115944_bb0525","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2012.28","article-title":"Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA","volume":"1","author":"Belliveau","year":"2012","journal-title":"Molecular Therapy - Nucleic Acids"},{"key":"10.1016\/j.addr.2026.115944_bb0530","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.66","article-title":"Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles","volume":"2","author":"Mui","year":"2013","journal-title":"Molecular Therapy - Nucleic Acids"},{"key":"10.1016\/j.addr.2026.115944_bb0585","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2014.09.025","article-title":"Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration","volume":"196","author":"Chen","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0535","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2026.115944_bb0540","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1039\/D2BM01846B","article-title":"Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury","volume":"11","author":"Waggoner","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb0545","doi-asserted-by":"crossref","first-page":"64219","DOI":"10.1021\/acsami.5c17052","article-title":"Effects of Serum Incubation on Lipid Nanoparticle PEG Shedding, mRNA Retention, and Membrane Interactions","volume":"17","author":"Niederkofler","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2026.115944_bb0550","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.2147\/IJN.S24344","article-title":"Effects of a novel pH-sensitive liposome with cleavable esterase-catalyzed and pH-responsive double smart mPEG lipid derivative on ABC phenomenon","volume":"6","author":"Chen","year":"2011","journal-title":"IJN"},{"key":"10.1016\/j.addr.2026.115944_bb0555","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1016\/j.biomaterials.2010.02.049","article-title":"Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes","volume":"31","author":"Xu","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115944_bb0560","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.7150\/thno.77259","article-title":"Lipid nanoparticles for delivery of RNA therapeutics: current status and the role of in vivo imaging","volume":"12","author":"Jung","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2026.115944_bb0565","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.addr.2026.115944_bb0570","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.1021\/acs.nanolett.9b03211","article-title":"Transcytosis of nanomedicine for tumor penetration","volume":"19","author":"Liu","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2026.115944_bb0575","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.actbio.2017.08.025","article-title":"Improved tumor tissue penetration and tumor cell uptake achieved by delayed charge reversal nanoparticles","volume":"62","author":"Gou","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2026.115944_bb0580","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1021\/mp400216r","article-title":"Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles","volume":"10","author":"Zhu","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115944_bb0815","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2026.115944_bb0820","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/znb-1955-0106","article-title":"An ein kolloidales Blutplasma-Ersatzmittel (Polyvinylpyrrolidon) gebundenes Peptamin (Glycyl-L-leucyl-mezcalin) als neuartige Depotform f\u00fcr biologisch aktive prim\u00e4re Amine (Mezcalin)","volume":"10","author":"Jatzkewitz","year":"1955","journal-title":"Zeitschrift f\u00fcr Naturforschung B"},{"key":"10.1016\/j.addr.2026.115944_bb0825","unstructured":"Serina Therapeutics. A Multi-Center, Open-Label, Multiple Ascending Dosage-Ranging Cohort (MAD) Study in Early, Untreated or Stably Treated Subjects With Parkinson\u2019s Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetics (PK) of Injections of SER-214 Administered Subcutaneously Once a Week for Two Weeks After 0-2 Weeks of Dose Titration. https:\/\/clinicaltrials.gov\/study\/NCT02579473 (2023)."},{"key":"10.1016\/j.addr.2026.115944_bb0830","doi-asserted-by":"crossref","first-page":"2494775","DOI":"10.1080\/10717544.2025.2494775","article-title":"PEGylation technology: addressing concerns, moving forward","volume":"32","author":"Simberg","year":"2025","journal-title":"Drug Deliv"},{"key":"10.1016\/j.addr.2026.115944_bb0835","first-page":"1049","article-title":"New Synthetic Amphiphilic Polymers for Steric Protection of Liposomes in Vivo","volume":"84","author":"Torchilin","year":"1995","journal-title":"JPharmSci"},{"key":"10.1016\/j.addr.2026.115944_bb0840","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/mds.28027","article-title":"Once-Weekly Subcutaneous Delivery of Polymer-Linked Rotigotine (SER-214) Provides Continuous Plasma Levels in Parkinson\u2019s Disease Patients","volume":"35","author":"Olanow","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.addr.2026.115944_bb0845","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nchem.1213","article-title":"Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity","volume":"4","author":"Keefe","year":"2012","journal-title":"Nat. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb0850","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nantod.2014.02.004","article-title":"Poly(carboxybetaine) nanomaterials enable long circulation and prevent polymer-specific antibody production","volume":"9","author":"Yang","year":"2014","journal-title":"Nano Today"},{"key":"10.1016\/j.addr.2026.115944_bb0855","doi-asserted-by":"crossref","first-page":"9135","DOI":"10.1016\/j.biomaterials.2012.09.007","article-title":"Influence of architecture of high molecular weight linear and branched polyglycerols on their biocompatibility and biodistribution","volume":"33","author":"ul-haq","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115944_bb0860","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1016\/j.biomaterials.2014.04.038","article-title":"The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticles","volume":"35","author":"Deng","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115944_bb1000","doi-asserted-by":"crossref","first-page":"2000406","DOI":"10.1002\/advs.202000406","article-title":"Sulfoxide-Containing Polymer-Coated Nanoparticles Demonstrate Minimal Protein Fouling and Improved Blood Circulation","volume":"7","author":"Qiao","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121676","article-title":"Polyglycerol and Poly(ethylene glycol) exhibit different effects on pharmacokinetics and antibody generation when grafted to nanoparticle surfaces","volume":"287","author":"Shin","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115944_bb0870","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/jps.23823","article-title":"Application of Polyglycerol Coating to Plasmid DNA Lipoplex for the Evasion of the Accelerated Blood Clearance Phenomenon in Nucleic Acid Delivery","volume":"103","author":"Abu Lila","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb0875","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jconrel.2009.10.017","article-title":"CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes","volume":"142","author":"Tagami","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb0880","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2013.07.059","article-title":"Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration","volume":"456","author":"Abu Lila","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2026.115944_bb0885","doi-asserted-by":"crossref","first-page":"7216","DOI":"10.1021\/acsnano.0c02289","article-title":"Polyglycerol Grafting Shields Nanoparticles from Protein Corona Formation to Avoid Macrophage Uptake","volume":"14","author":"Zou","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115944_bb0890","doi-asserted-by":"crossref","first-page":"17073","DOI":"10.1021\/acs.chemrev.2c00344","article-title":"Zwitterionic biomaterials","volume":"122","author":"Li","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.addr.2026.115944_bb0965","doi-asserted-by":"crossref","first-page":"eaaw9562","DOI":"10.1126\/sciadv.aaw9562","article-title":"Trimethylamine N-oxide\u2013derived zwitterionic polymers: A new class of ultralow fouling bioinspired materials","volume":"5","author":"Li","year":"2019","journal-title":"Science Advances"},{"key":"10.1016\/j.addr.2026.115944_bb0970","doi-asserted-by":"crossref","first-page":"16786","DOI":"10.1021\/jacs.1c08280","article-title":"Strong Surface Hydration and Salt Resistant Mechanism of a New Nonfouling Zwitterionic Polymer Based on Protein Stabilizer TMAO","volume":"143","author":"Huang","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115944_bb0895","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1080\/09205063.2022.2034285","article-title":"Determination of non-freezing water in different nonfouling materials by differential scanning calorimetry","volume":"33","author":"Ma","year":"2022","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.addr.2026.115944_bb0900","doi-asserted-by":"crossref","first-page":"12046","DOI":"10.1073\/pnas.1512465112","article-title":"Zwitterionic gel encapsulation promotes protein stability, enhances pharmacokinetics, and reduces immunogenicity","volume":"112","author":"Zhang","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb0905","doi-asserted-by":"crossref","first-page":"8561","DOI":"10.1039\/C8SC01777H","article-title":"Zwitterlation mitigates protein bioactivity loss in vitro over PEGylation","volume":"9","author":"Han","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb0910","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/s41563-025-02240-8","article-title":"Poly(carboxybetaine) lipids enhance mRNA therapeutics efficacy and reduce their immunogenicity","volume":"24","author":"Luozhong","year":"2025","journal-title":"Nat. Mater."},{"key":"10.1016\/j.addr.2026.115944_bb0915","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.3390\/ma18194514","article-title":"Zwitterionic poly(carboxybetaine methacrylate)s in drug delivery, antifouling coatings, and regenerative tissue platforms","volume":"18","author":"Sentoukas","year":"2025","journal-title":"Materials"},{"key":"10.1016\/j.addr.2026.115944_bb0920","doi-asserted-by":"crossref","first-page":"eabc5442","DOI":"10.1126\/sciadv.abc5442","article-title":"High-strength and fibrous capsule\u2013resistant zwitterionic elastomers","volume":"7","author":"Dong","year":"2021","journal-title":"Science Advances"},{"key":"10.1016\/j.addr.2026.115944_bb0925","doi-asserted-by":"crossref","first-page":"583","DOI":"10.7150\/thno.11234","article-title":"Zwitterionic poly(carboxybetaine)-based cationic liposomes for effective delivery of small interfering RNA therapeutics without accelerated blood clearance phenomenon","volume":"5","author":"Li","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2026.115944_bb0930","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2014.11.010","article-title":"Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior","volume":"41","author":"Li","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115944_bb0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119521","article-title":"Blood retention and antigenicity of polycarboxybetaine-modified liposomes","volume":"586","author":"Ryujin","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2026.115944_bb0940","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3390\/pharmaceutics16101271","article-title":"A stealthiness evaluation of main chain carboxybetaine polymer modified into liposome","volume":"16","author":"Najmina","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2026.115944_bb0945","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.colsurfb.2016.07.016","article-title":"Different in vitro and in vivo behaviors between Poly(carboxybetaine methacrylate) and poly(sulfobetaine methacrylate)","volume":"146","author":"Lin","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.addr.2026.115944_bb0955","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1021\/jp3094534","article-title":"Effect of carbon spacer length on zwitterionic carboxybetaines","volume":"117","author":"Shao","year":"2013","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.addr.2026.115944_bb0960","doi-asserted-by":"crossref","first-page":"13365","DOI":"10.1021\/acs.langmuir.4c00456","article-title":"Effects of Carbon Spacer Length on Conformational Transitions and Protein Adsorption of Polyzwitterions","volume":"40","author":"Zhang","year":"2024","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2026.115944_bb0990","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0166-1280(92)85003-4","article-title":"An observable-based interpretation of electronic wavefunctions: application to \u201chypervalent\u201d molecules","volume":"255","author":"Cioslowski","year":"1992","journal-title":"J. Mol. Struct. THEOCHEM"},{"key":"10.1016\/j.addr.2026.115944_bb0995","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00894-008-0279-y","article-title":"Why are dimethyl sulfoxide and dimethyl sulfone such good solvents?","volume":"14","author":"Clark","year":"2008","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.addr.2026.115944_bb0985","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jconrel.2024.05.050","article-title":"Sulfoxide-containing polymers conjugated prodrug micelles with enhanced anticancer activity and reduced intestinal toxicity","volume":"371","author":"Wang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb1005","article-title":"PEG-free Lipid Nanoparticles for mRNA Delivery: Superhydrophilic Sulfoxide Polymer Coatings","volume":"10","author":"Choy","year":"2026","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115944_bb1010","doi-asserted-by":"crossref","first-page":"24531","DOI":"10.1021\/acsami.9b22495","article-title":"Think beyond the core: Impact of the hydrophilic corona on drug solubilization using polymer micelles","volume":"12","author":"Haider","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2026.115944_bb1020","doi-asserted-by":"crossref","first-page":"41839","DOI":"10.1021\/acsami.8b17193","article-title":"Mixing Poly(ethylene glycol) and Poly(2-alkyl-2-oxazoline)s Enhances Hydration and Viscoelasticity of Polymer Brushes and Determines Their Nanotribological and Antifouling Properties","volume":"10","author":"Morgese","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2026.115944_bb1015","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1021\/acs.chemmater.8b01882","article-title":"Drug-Induced Morphology Transition of Self-Assembled Glycopolymers: Insight into the Drug\u2013Polymer Interaction","volume":"30","author":"Cao","year":"2018","journal-title":"Chem. Mater."},{"key":"10.1016\/j.addr.2026.115944_bb1025","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1021\/acs.chemmater.3c00644","article-title":"Exploring the Effect of Drug Loading on the Biological Fate of Polymer-Coated Solid Nanoparticles","volume":"35","author":"Zhang","year":"2023","journal-title":"Chem. Mater."},{"key":"10.1016\/j.addr.2026.115944_bb1030","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.biomaterials.2016.06.002","article-title":"A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity","volume":"101","author":"He","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115944_bb1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121140","article-title":"Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane in rodent and non-human primate models using a stable isotope tracer assay","volume":"278","author":"Hwang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115944_bb1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101884","article-title":"High-dose paclitaxel and its combination with CSF1R inhibitor in polymeric micelles for chemoimmunotherapy of triple negative breast cancer","volume":"51","author":"Lim","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.addr.2026.115944_bb1045","article-title":"Machine learning-enhanced engineering of ultrahigh-loading polymer-drug assemblies with programmable ROS-triggered release for tumor elimination","author":"d\u2019Arcy","year":"2026","journal-title":"ResearchSquare"},{"key":"10.1016\/j.addr.2026.115944_bb1050","article-title":"Think beyond the core: Computationally decoding the hydrophilic corona of drug-loaded polymer micelles","author":"Karachevtsev","year":"2026","journal-title":"ChemRxiv"},{"key":"10.1016\/j.addr.2026.115944_bb1055","doi-asserted-by":"crossref","DOI":"10.1016\/j.progpolymsci.2024.101867","article-title":"Polymer-mediated protein\/peptide therapeutic stabilization: Current progress and future directions","volume":"156","author":"Sivasankaran","year":"2024","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb1060","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41570-022-00407-4","article-title":"Chemical approaches to cryopreservation","volume":"6","author":"Murray","year":"2022","journal-title":"Nat Rev Chem"},{"key":"10.1016\/j.addr.2026.115944_bb1065","doi-asserted-by":"crossref","first-page":"E501","DOI":"10.1208\/aapsj080359","article-title":"Effects of protein aggregates: An immunologic perspective","volume":"8","author":"Rosenberg","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.addr.2026.115944_bb1070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2026.115944_bb1075","doi-asserted-by":"crossref","first-page":"8474","DOI":"10.1021\/ja2120234","article-title":"Trehalose Glycopolymers for Stabilization of Protein Conjugates to Environmental Stressors","volume":"134","author":"Mancini","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115944_bb1080","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1021\/acs.bioconjchem.6b00659","article-title":"Trehalose Glycopolymer Enhances Both Solution Stability and Pharmacokinetics of a Therapeutic Protein","volume":"28","author":"Liu","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb1085","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.xphs.2020.12.006","article-title":"Addressing the cold reality of mRNA vaccine stability","volume":"110","author":"Crommelin","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb1090","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/vaccines9091033","article-title":"Challenges of storage and stability of mRNA-based COVID-19 vaccines","volume":"9","author":"Uddin","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.addr.2026.115944_bb1095","series-title":"2019 Biopharma Cold-Chain Logistics Survey: What Matters Most \u2014 and What It Means for the Future","author":"BioThermal","year":"2019"},{"key":"10.1016\/j.addr.2026.115944_bb1100","author":"M\u00e9decins Sans Fronti\u00e8res"},{"key":"10.1016\/j.addr.2026.115944_bb1110","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/S0021-9258(17)40292-4","article-title":"Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase","volume":"252","author":"Abuchowski","year":"1977","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.addr.2026.115944_bib2091","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/S0021-9258(17)40292-4","article-title":"Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase","volume":"252","author":"Abuchowski","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1016\/j.addr.2026.115944_bb1115","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid NanoparticlesFrom Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115944_bb1120","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.bbapap.2013.01.020","article-title":"Unraveling protein stabilization mechanisms: Vitrification and water replacement in a glass transition temperature controlled system","volume":"1834","author":"Grasmeijer","year":"2013","journal-title":"Biochim. Biophy. Acta Proteins Proteomics"},{"key":"10.1016\/j.addr.2026.115944_bb1125","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1021\/bm400217j","article-title":"Antifreeze (Glyco)protein Mimetic Behavior of Poly(vinyl alcohol): Detailed Structure Ice Recrystallization Inhibition Activity Study","volume":"14","author":"Congdon","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115944_bb1135","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1038\/s41467-022-34300-x","article-title":"Janus regulation of ice growth by hyperbranched polyglycerols generating dynamic hydrogen bonding","volume":"13","author":"Lee","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115944_bb1140","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1021\/acs.biomac.4c01462","article-title":"Synergistic effect of polyglycerol and DMSO for long-term cryopreservation of Stichococcus species","volume":"26","author":"Aram","year":"2025","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115944_bb1145","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1021\/acs.biomac.0c01627","article-title":"Polyglycerol for Half-Life Extension of Proteins\u2014Alternative to PEGylation?","volume":"22","author":"Tully","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115944_bb1150","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1021\/bm4003046","article-title":"Trehalose Glycopolymers as Excipients for Protein Stabilization","volume":"14","author":"Lee","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115944_bb1155","doi-asserted-by":"crossref","first-page":"37410","DOI":"10.1021\/acsami.2c09301","article-title":"Poly(trehalose methacrylate) as an Excipient for Insulin Stabilization: Mechanism and Safety","volume":"14","author":"Gelb","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2026.115944_bb1160","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1039\/C7TB02720F","article-title":"Synthetic glycopolymers as modulators of protein aggregation: influences of chemical composition, topology and concentration","volume":"6","author":"Madeira Do","year":"2018","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.addr.2026.115944_bb1165","doi-asserted-by":"crossref","first-page":"1900082","DOI":"10.1002\/mabi.201900082","article-title":"Mimicking the Ice Recrystallization Activity of Biological Antifreezes. When is a New Polymer \u201cActive\u201d?","volume":"19","author":"Biggs","year":"2019","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.addr.2026.115944_bib2094","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/s41467-021-21717-z","article-title":"The atomistic details of the ice recrystallisation inhibition activity of PVA","volume":"12","author":"Bachtiger","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.addr.2026.115944_bb1170","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1039\/C8MH00727F","article-title":"Ice-recrystallization inhibiting polymers protect proteins against freeze-stress and enable glycerol-free cryostorage","volume":"6","author":"Mitchell","year":"2019","journal-title":"Mater. Horiz."},{"key":"10.1016\/j.addr.2026.115944_bb1175","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1021\/acs.biomac.8b00660","article-title":"Ice Recrystallization Inhibiting Polymers Enable Glycerol-Free Cryopreservation of Microorganisms","volume":"19","author":"Hasan","year":"2018","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115944_bb1180","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1189\/jlb.1204697","article-title":"Myeloperoxidase: friend and foe","volume":"77","author":"Klebanoff","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.addr.2026.115944_bb1185","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"10","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.addr.2026.115944_bb1190","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.redox.2016.12.035","article-title":"Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative eustress","volume":"11","author":"Sies","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.addr.2026.115944_bb1195","first-page":"794","article-title":"Production of large amounts of hydrogen peroxide by human tumor cells","volume":"51","author":"Szatrowski","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2026.115944_bb1200","doi-asserted-by":"crossref","first-page":"2501746","DOI":"10.1002\/adhm.202501746","article-title":"Tumor Microenvironment-responsive Nanocatalyst for Targeted Chemodynamic Cancer Therapy","volume":"14","author":"Ma","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2026.115944_bb1205","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cmet.2017.12.013","article-title":"Apoptotic Regulatory T Cells Retain Suppressive Function through Adenosine","volume":"27","author":"Beier","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.addr.2026.115944_bb1210","doi-asserted-by":"crossref","first-page":"1900038","DOI":"10.1002\/adtp.201900038","article-title":"Reactive Oxygen Species-Responsive Nanoparticles for the Treatment of Ischemic Stroke","volume":"2","author":"Rajkovic","year":"2019","journal-title":"Advanced Therapeutics"},{"key":"10.1016\/j.addr.2026.115944_bb1215","article-title":"ROS-responsive nanoparticle as a berberine carrier for OHC-targeted therapy of noise-induced hearing loss","volume":"10","author":"Li","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2026.115944_bb1230","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.3390\/ijms20184583","article-title":"Main Chain Polysulfoxides as Active \u2018Stealth\u2019 Polymers with Additional Antioxidant and Anti-Inflammatory Behaviour","volume":"20","author":"El Mohtadi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb1235","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1039\/D0SM01987A","article-title":"Designing responsive dressings for inflammatory skin disorders; encapsulating antioxidant nanoparticles into biocompatible electrospun fibres","volume":"17","author":"Brooker","year":"2021","journal-title":"Soft Matter"},{"key":"10.1016\/j.addr.2026.115944_bb1240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213537","article-title":"Polysulfide nanoparticles inhibit fibroblast-to-myofibroblast transition via extracellular ROS scavenging and have potential anti-fibrotic properties","volume":"153","author":"Siani","year":"2023","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.addr.2026.115944_bb1245","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/pat.3264","article-title":"Fishing for fire: strategies for biological targeting and criteria for material design in anti-inflammatory therapies","volume":"25","author":"d\u2019Arcy","year":"2014","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.addr.2026.115944_bb1250","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1039\/c3py01475d","article-title":"Chemical specificity in REDOX-responsive materials: the diverse effects of different Reactive Oxygen Species (ROS) on polysulfide nanoparticles","volume":"5","author":"Jeanmaire","year":"2014","journal-title":"Polym. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb1255","doi-asserted-by":"crossref","first-page":"2400894","DOI":"10.1002\/adma.202400894","article-title":"Neutrophil Extracellular Traps-Inhibiting and Fouling-Resistant Polysulfoxides Potently Prevent Postoperative Adhesion, Tumor Recurrence, and Metastasis","volume":"36","author":"Wang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2026.115944_bb1260","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11095-018-2467-5","article-title":"Mitigation of Oxidation in Therapeutic Antibody Formulations: a Biochemical Efficacy and Safety Evaluation of N-Acetyl-Tryptophan and L-Methionine","volume":"35","author":"Dion","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2026.115944_bb1265","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.molimm.2010.12.009","article-title":"Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies","volume":"48","author":"Wang","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.addr.2026.115944_bb1270","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jps.24136","article-title":"Effect of Individual Fc Methionine Oxidation on FcRn Binding: Met252 Oxidation Impairs FcRn Binding More Profoundly than Met428 Oxidation","volume":"104","author":"Gao","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb1275","article-title":"High-concentration L-methionine as a potent antioxidant for oxidation resistance and stability enhancement in high-concentration antibody therapeutics","volume":"10","author":"Wang","year":"2025","journal-title":"International Journal of Pharmaceutics: X"},{"issue":"7","key":"10.1016\/j.addr.2026.115944_bib2092","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/j.xphs.2021.03.017","article-title":"A review of Formulations of Commercially Available Antibodies","volume":"110","author":"Strickley","year":"2021","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.addr.2026.115944_bb1280","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1146\/annurev-biochem-060815-014442","article-title":"Reactive Oxygen Species and Neutrophil Function","volume":"85","author":"Winterbourn","year":"2016","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.addr.2026.115944_bb1285","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.xphs.2019.08.005","article-title":"Proteolysis and Oxidation of Therapeutic Proteins After Intradermal or Subcutaneous Administration","volume":"109","author":"Varkhede","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb1290","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s42003-018-0032-8","article-title":"Assessment of susceptible chemical modification sites of trastuzumab and endogenous human immunoglobulins at physiological conditions","volume":"1","author":"Schmid","year":"2018","journal-title":"Commun. Biol."},{"key":"10.1016\/j.addr.2026.115944_bb1295","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","article-title":"Oxidative Stress in Cancer","volume":"38","author":"Hayes","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.addr.2026.115944_bb1300","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc3803","article-title":"Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles\u2019 heel?","volume":"14","author":"Sabharwal","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.addr.2026.115944_bb1305","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive Oxygen Species in Inflammation and Tissue Injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.addr.2026.115944_bb1310","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/CIRCRESAHA.117.311401","article-title":"Reactive Oxygen Species in Metabolic and Inflammatory Signaling","volume":"122","author":"Forrester","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2026.115944_bb1220","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1039\/C8BM01224E","article-title":"Celastrol-loaded PEG-b-PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis","volume":"7","author":"Allen","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb1225","article-title":"Self-assembly of PEG-PPS polymers and LL-37 peptide nanomicelles improves the oxidative microenvironment and promotes angiogenesis to facilitate chronic wound healing","volume":"10","author":"Shi","year":"2024","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.addr.2026.115944_bb1315","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41565-019-0485-z","article-title":"Enzyme-activatable polymer\u2013drug conjugate augments tumour penetration and treatment efficacy","volume":"14","author":"Zhou","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2026.115944_bb1320","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1021\/acsnano.0c00974","article-title":"Enzyme-Triggered Transcytosis of Dendrimer\u2013Drug Conjugate for Deep Penetration into Pancreatic Tumors","volume":"14","author":"Wang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115944_bb1325","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1021\/acs.bioconjchem.2c00391","article-title":"Hydrophobicity Effects of \u03b3-Glutamyl Transpeptidase-Responsive Polymers on the Catalytic Activity and Transcytosis Efficacy","volume":"33","author":"Zhou","year":"2022","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb1330","article-title":"Aminopeptidase n-responsive conjugates with tunable charge-reversal properties for highly efficient tumor accumulation and penetration","volume":"62","author":"Sun","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115944_bb1335","article-title":"Dual Enzyme-Responsive Polymer-Drug Conjugates Induce Diverse Cells Mutual Transcytosis to Achieve Deep Pancreatic Tumor Penetration","volume":"64","author":"Sun","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115944_bb1340","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1002\/adma.201501803","article-title":"Therapeutic Enzyme-Responsive Nanoparticles for Targeted Delivery and Accumulation in Tumors","volume":"27","author":"Callmann","year":"2015","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2026.115944_bb1345","doi-asserted-by":"crossref","first-page":"18710","DOI":"10.1021\/ja408182p","article-title":"Enzyme-directed assembly of nanoparticles in tumors monitored by in vivo whole animal imaging and ex vivo super-resolution fluorescence imaging","volume":"135","author":"Chien","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115944_bb1350","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1021\/acscentsci.8b00444","article-title":"Tumor Retention of Enzyme-Responsive Pt(II) Drug-Loaded Nanoparticles Imaged by Nanoscale Secondary Ion Mass Spectrometry and Fluorescence Microscopy","volume":"4","author":"Proetto","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb1355","doi-asserted-by":"crossref","first-page":"1901105","DOI":"10.1002\/adhm.201901105","article-title":"Delivery of Immunotherapeutic Nanoparticles to Tumors via Enzyme-Directed Assembly","volume":"8","author":"Battistella","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2026.115944_bb1360","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1021\/acs.biomac.3c00421","article-title":"Enzyme-responsive nanoparticles for the targeted delivery of an MMP inhibitor to acute myocardial infarction","volume":"24","author":"Sullivan","year":"2023","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115944_bb1365","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1021\/acs.biomac.5b00929","article-title":"Enzymatically triggered, isothermally responsive polymers: Reprogramming poly(oligoethylene glycols) to respond to phosphatase","volume":"16","author":"Phillips","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115944_bb1370","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1021\/jacs.2c10188","article-title":"Hypoxia-triggered bioreduction of poly(n-oxide)\u2013drug conjugates enhances tumor penetration and antitumor efficacy","volume":"145","author":"Zhang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115944_bb1555","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jconrel.2011.06.013","article-title":"RAFT-synthesized graft copolymers that enhance pH-dependent membrane destabilization and protein circulation times","volume":"155","author":"Crownover","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb1560","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1021\/bc100204m","article-title":"Intracellular delivery of a protein antigen with an endosomal-releasing polymer enhances CD8 T-cell production and prophylactic vaccine efficacy","volume":"21","author":"Foster","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb1565","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1039\/C3SC52233D","article-title":"Reversibly switchable polymer with cationic\/zwitterionic\/anionic behavior through synergistic protonation and deprotonation","volume":"5","author":"Sundaram","year":"2014","journal-title":"Chem. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb1595","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/acb394","article-title":"Synthesis of pH-responsive polyzwitterions for activated cellular uptake and tumor accumulation of gold nanoparticles at tumorous acidity","volume":"18","author":"Hu","year":"2023","journal-title":"Biomed. Mater."},{"key":"10.1016\/j.addr.2026.115944_bb1570","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1002\/adma.201202296","article-title":"Surface Charge Switchable Nanoparticles Based on Zwitterionic Polymer for Enhanced Drug Delivery to Tumor","volume":"24","author":"Yuan","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2026.115944_bb1575","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.7150\/thno.47849","article-title":"Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery","volume":"10","author":"Wang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2026.115944_bb1580","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1002\/anie.201411615","article-title":"Acylsulfonamide-Functionalized Zwitterionic Gold Nanoparticles for Enhanced Cellular Uptake at Tumor pH","volume":"54","author":"Mizuhara","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115944_bb1585","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1007\/s12274-017-1736-7","article-title":"pH-sensitive zwitterionic coating of gold nanocages improves tumor targeting and photothermal treatment efficacy","volume":"11","author":"Piao","year":"2018","journal-title":"Nano Res."},{"key":"10.1016\/j.addr.2026.115944_bb1590","article-title":"Engineering polyzwitterion with acylsulfonamide-based betaine structure for protonated switch of surface chemistry at tumoral pH and reductive responsive drug release of polymeric micelles","volume":"17","author":"Zhou","year":"2020","journal-title":"Mater. Today Chem."},{"key":"10.1016\/j.addr.2026.115944_bb1600","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1002\/anie.201801641","article-title":"An Ethylenediamine-based Switch to Render the Polyzwitterion Cationic at Tumorous pH for Effective Tumor Accumulation of Coated Nanomaterials","volume":"57","author":"Ranneh","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115944_bb1605","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1021\/acs.biomac.4c01086","article-title":"Synthesis and Optimization of Ethylenediamine-Based Zwitterion on Polymer Side Chain for Recognizing Narrow Tumorous pH Windows","volume":"25","author":"Toyoda","year":"2024","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115944_bb1610","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1111\/cas.15554","article-title":"Cancerous pH-responsive polycarboxybetaine-coated lipid nanoparticle for smart delivery of siRNA against subcutaneous tumor model in mice","volume":"113","author":"Sung","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.addr.2026.115944_bb1615","doi-asserted-by":"crossref","first-page":"8508","DOI":"10.1021\/acs.biomac.5c01343","article-title":"Polyzwitterion-Based pH-Responsive Shell of Polymeric Micelle: Evaluation of Physicochemical Properties and In Vivo Functionalities","volume":"26","author":"Chintrakulchai","year":"2025","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115944_bb1625","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/jb\/mvt085","article-title":"Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer","volume":"154","author":"Heldin","year":"2013","journal-title":"J. Biochem."},{"key":"10.1016\/j.addr.2026.115944_bb1630","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00201","article-title":"Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer","volume":"6","author":"Misra","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2026.115944_bb1690","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1021\/acs.nanolett.6b00068","article-title":"Hyaluronidase to enhance nanoparticle-based photodynamic tumor therapy","volume":"16","author":"Gong","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2026.115944_bb1830","doi-asserted-by":"crossref","first-page":"1331480","DOI":"10.3389\/fimmu.2024.1331480","article-title":"Host-functionalization of macrin nanoparticles to enable drug loading and control tumor-associated macrophage phenotype","volume":"15","author":"Sarkar","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2026.115944_bb1875","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/path.1027","article-title":"The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies","volume":"196","author":"Bingle","year":"2002","journal-title":"J. Pathol."},{"key":"10.1016\/j.addr.2026.115944_bb1895","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1021\/acsnano.7b06995","article-title":"Directing nanoparticle biodistribution through evasion and exploitation of stab2-dependent nanoparticle uptake","volume":"12","author":"Campbell","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115944_bb1900","article-title":"Stabilin-1 is required for the endothelial clearance of small anionic nanoparticles","volume":"34","author":"Arias-Alpizar","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2026.115944_bb1905","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1093\/nar\/gkw112","article-title":"Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver","volume":"44","author":"Miller","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2026.115944_bb1910","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1038\/s41467-024-48838-5","article-title":"Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery","volume":"15","author":"Zelepukin","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115944_bb1915","doi-asserted-by":"crossref","first-page":"76","DOI":"10.29016\/180430.1","article-title":"Discrepancies in the in vitro and in vivo role of scavenger receptors in clearance of nanoparticles by Kupffer cells","volume":"1","author":"Wang","year":"2018","journal-title":"Precis Nanomed"},{"key":"10.1016\/j.addr.2026.115944_bb1920","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/acsnano.9b04571","article-title":"Tuning Ligand Density To Optimize Pharmacokinetics of Targeted Nanoparticles for Dual Protection against Tumor-Induced Bone Destruction","volume":"14","author":"Vanderburgh","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115944_bb1925","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jaip.2018.12.003","article-title":"Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized","volume":"7","author":"Stone","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.addr.2026.115944_bb1930","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/jama.2021.1967","article-title":"Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US\u2014December 14, 2020-January 18, 2021","volume":"325","author":"Shimabukuro","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2026.115944_bb1935","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jaci.2015.07.048","article-title":"Risk of anaphylaxis after vaccination in children and adults","volume":"137","author":"McNeil","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.addr.2026.115944_bb1940","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115944_bb1960","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2015.11.010","article-title":"Elastin-like polypeptides: Therapeutic applications for an emerging class of nanomedicines","volume":"240","author":"Despanie","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb1965","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jconrel.2020.08.065","article-title":"Temperature-triggered micellization of interferon alpha-diblock copolypeptide conjugate with enhanced stability and pharmacology","volume":"328","author":"Wang","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115944_bb1970","doi-asserted-by":"crossref","first-page":"7834","DOI":"10.1158\/1078-0432.CCR-05-0803","article-title":"A Phase I and Pharmacokinetic Study of Paclitaxel Poliglumex (XYOTAX), Investigating Both 3-Weekly and 2-Weekly Schedules","volume":"11","author":"Boddy","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2026.115944_bb1975","doi-asserted-by":"crossref","first-page":"21693","DOI":"10.1039\/D5NR01680K","article-title":"Asymmetrical branched PEG-modified liposomes evade anti-PEG antibody recognition to abolish accelerated blood clearance and amplify tumor drug accumulation","volume":"17","author":"Zhang","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.addr.2026.115944_bb1980","first-page":"66669","volume":"84","year":"2019","journal-title":"Fed. Regist."},{"key":"10.1016\/j.addr.2026.115944_bb2075","first-page":"50442","article-title":"Center for Drug Evaluation and Research. Center for Drug Evaluation and Research Office of New Drugs Novel Excipient Review Pilot Program","volume":"86","author":"Food","year":"2021","journal-title":"Fed. Regist."},{"key":"10.1016\/j.addr.2026.115944_bb1985","series-title":"European Pharmacopoeia","author":"Macrogols","year":"2003"},{"key":"10.1016\/j.addr.2026.115944_bb1990","series-title":"United States Pharmacopeia\u2013National Formulary (USP\u2013NF)","author":"Polyethylene Glycol","year":"2020"},{"key":"10.1016\/j.addr.2026.115944_bb1995","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/jps.24257","article-title":"Chemical Modifications of Therapeutic Proteins Induced by Residual Ethylene Oxide","volume":"104","author":"Chen","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115944_bb2000","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1039\/c0py00406e","article-title":"Overcoming the PEG-addiction: well-defined alternatives to PEG, from structure\u2013property relationships to better defined therapeutics","volume":"2","author":"Barz","year":"2011","journal-title":"Polym. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb2005","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/marc.200800740","article-title":"Polymers and Sulfur: what are Organic Polysulfides Good For? Preparative Strategies and Biological Applications","volume":"30","author":"Vo","year":"2009","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.addr.2026.115944_bb2010","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1021\/jacs.3c14740","article-title":"Precision Synthesis of Polysarcosine via Controlled Ring-Opening Polymerization of N -Carboxyanhydride: Fast Kinetics, Ultrahigh Molecular Weight, and Mechanistic Insights","volume":"146","author":"Wang","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115944_bb2020","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1021\/bm901129x","article-title":"In Vitro Cytotoxicity of RAFT Polymers","volume":"11","author":"Pissuwan","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115944_bb2025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1039\/B9PY00340A","article-title":"End group removal and modification of RAFT polymers","volume":"1","author":"Willcock","year":"2010","journal-title":"Polym. Chem."},{"key":"10.1016\/j.addr.2026.115944_bb2030","doi-asserted-by":"crossref","first-page":"10084","DOI":"10.1021\/acs.macromol.5c01887","article-title":"Exploring the Removal of Thiocarbonylthio Chain Ends from Poly(styrene- alt -maleic anhydride) Copolymers","volume":"58","author":"Smith","year":"2025","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2026.115944_bb2035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40259-015-0133-6","article-title":"Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters","volume":"29","author":"Strohl","year":"2015","journal-title":"BioDrugs"},{"key":"10.1016\/j.addr.2026.115944_bb2040","unstructured":"Sodium Hyaluronate. in European Pharmacopoeia (ed. Council of Europe) (Council of Europe, Strasbourg)."},{"issue":"2\u20133","key":"10.1016\/j.addr.2026.115944_bib2093","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12026-014-8495-2","article-title":"Tissue integrity signals communicated by high-molecular weight hyaluronan and the resolution of inflammation","volume":"58","author":"Ruppert","year":"2014","journal-title":"Immunologic research"},{"key":"10.1016\/j.addr.2026.115944_bb2045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jbm.b.31570","article-title":"Role of protein contaminants in the immunogenicity of alginates","volume":"93B","author":"M\u00e9nard","year":"2010","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.addr.2026.115944_bb2050","article-title":"Reducing endotoxin contamination in chitosan: An optimized purification method for biomedical applications","volume":"10","author":"Ghattas","year":"2025","journal-title":"Carbohydr. Polym. Technol. Appl."},{"key":"10.1016\/j.addr.2026.115944_bb2055","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jvs.2006.01.006","article-title":"Anaphylactoid reactions to Dextran 40 and 70: Reports to the United States Food and Drug Administration, 1969 to 2004","volume":"43","author":"Zinderman","year":"2006","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.addr.2026.115944_bb2060","first-page":"179","article-title":"Incidence, pathomechanism and prevention of dextran-induced anaphylactoid \/ anaphylactic reactions in man","volume":"48","author":"Hedin","year":"1980","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.addr.2026.115944_bb2065","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1056\/NEJMoa0806450","article-title":"Outbreak of Adverse Reactions Associated with Contaminated Heparin","volume":"359","author":"Blossom","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2026.115944_bb2070","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/elsc.201600220","article-title":"Polysialic acid production using Escherichia coli K1 in a disposable bag reactor","volume":"17","author":"de Vries","year":"2017","journal-title":"Eng. Life Sci."},{"key":"10.1016\/j.addr.2026.115944_bb2080","author":"U.S. Food and Drug Administration, Center for Drug Evaluation and Research, & Center for Biologics Evaluation and Research"},{"key":"10.1016\/j.addr.2026.115944_bb2085","series-title":"21 C.F.R. \u00a7 210.3(b)(7)-(8) - Definitions: Active Ingredient; Inactive Ingredient","first-page":"156","volume":"4","author":"U.S. Government Publishing Office","year":"2024"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X2600178X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X2600178X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:18:27Z","timestamp":1789121907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X2600178X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":418,"alternative-id":["S0169409X2600178X"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2026.115944","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond PEG: Re-Engineering stealth-polymers to do more than just hide","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2026.115944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115944"}}